In addition to inducing angiogenic factors (e.g., vascular endothelial growth factor/VEGF and prostaglandin E2/PGE2), Th17 cells can activate oncogenic IL-6/Stat3 signaling to enhance tumor growth (48). Here, VEGFA is linked to neoplasm.